HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arndt Hartmann Selected Research

Formaldehyde (Formol)

1/2022Expression of Prostate-specific Membrane Antigen (PSMA) in Papillary Renal Cell Carcinoma - Overview and Report on a Large Multicenter Cohort.
3/2021miRNA Expression Characterizes Histological Subtypes and Metastasis in Penile Squamous Cell Carcinoma.
11/2019Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays.
1/2019FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non-muscle-invasive bladder cancer.
1/2018High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients.
1/2018Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor.
1/2018Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS).
11/2017An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
9/2017Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsies.
7/2017FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arndt Hartmann Research Topics

Disease

282Neoplasms (Cancer)
07/2022 - 03/2002
86Carcinoma (Carcinomatosis)
10/2022 - 05/2002
79Breast Neoplasms (Breast Cancer)
01/2022 - 01/2004
75Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 03/2002
48Renal Cell Carcinoma (Grawitz Tumor)
10/2022 - 03/2003
26Prostatic Neoplasms (Prostate Cancer)
05/2022 - 04/2005
24Neoplasm Metastasis (Metastasis)
05/2022 - 09/2004
22Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 09/2004
20Non-Muscle Invasive Bladder Neoplasms
01/2022 - 05/2012
19Carcinogenesis
01/2019 - 11/2002
13Colonic Neoplasms (Colon Cancer)
01/2022 - 09/2004
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 01/2006
11Inflammation (Inflammations)
07/2022 - 03/2010
11Microsatellite Instability
11/2021 - 02/2003
10Rectal Neoplasms (Rectal Cancer)
12/2021 - 02/2012
10Squamous Cell Carcinoma of Head and Neck
12/2021 - 01/2006
10Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 05/2007
10Lymphatic Metastasis
02/2021 - 05/2008
9Disease Progression
01/2022 - 04/2010
8Adenocarcinoma
10/2022 - 01/2008
8Margins of Excision
01/2022 - 06/2009
7Hypoxia (Hypoxemia)
01/2022 - 04/2009
7Melanoma (Melanoma, Malignant)
01/2021 - 04/2005
7Hepatocellular Carcinoma (Hepatoma)
01/2018 - 05/2005
6Triple Negative Breast Neoplasms
12/2021 - 06/2017
6Sarcoma (Soft Tissue Sarcoma)
01/2021 - 06/2014
6Adenoma (Adenomas)
04/2016 - 04/2007
5Lung Neoplasms (Lung Cancer)
01/2022 - 05/2007
5Adenocarcinoma of Lung
01/2022 - 12/2014
5Ovarian Neoplasms (Ovarian Cancer)
06/2021 - 03/2007
5Leiomyomatosis
11/2020 - 01/2013
5Ulcerative Colitis
05/2020 - 09/2010
4Noninfiltrating Intraductal Carcinoma (DCIS)
10/2022 - 11/2007
4Endometrial Neoplasms (Endometrial Cancer)
11/2021 - 12/2008
4Infections
09/2021 - 10/2003
4Papillomavirus Infections
03/2021 - 05/2007
4Acinar Cell Carcinoma
02/2021 - 06/2008

Drug/Important Bio-Agent (IBA)

111Proteins (Proteins, Gene)FDA Link
11/2022 - 11/2002
56Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2008
54Messenger RNA (mRNA)IBA
01/2022 - 10/2003
33ParaffinIBA
01/2022 - 08/2002
31DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2002
29Phenobarbital (Luminal)FDA Link
11/2021 - 01/2007
27Formaldehyde (Formol)FDA Link
01/2022 - 04/2005
25RNA (Ribonucleic Acid)IBA
12/2021 - 10/2003
23Hormones (Hormone)IBA
11/2021 - 11/2008
19Biological ProductsIBA
01/2022 - 11/2002
14MicroRNAs (MicroRNA)IBA
03/2021 - 04/2010
13Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 11/2009
13Estrogen ReceptorsIBA
09/2021 - 12/2008
12Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2008
11Immune Checkpoint InhibitorsIBA
01/2022 - 11/2016
11B7-H1 AntigenIBA
11/2021 - 01/2016
9PlatinumIBA
04/2022 - 03/2007
9AntibodiesIBA
01/2022 - 01/2006
9Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
01/2021 - 08/2007
9Cadherins (E-Cadherin)IBA
08/2020 - 02/2009
9Codon (Codons)IBA
01/2018 - 05/2002
8Cisplatin (Platino)FDA LinkGeneric
04/2021 - 08/2010
8AcidsIBA
11/2017 - 03/2002
7Keratins (Keratin)IBA
02/2022 - 03/2011
7Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2022 - 08/2006
7Androgen Receptors (Androgen Receptor)IBA
06/2021 - 06/2017
6LigandsIBA
01/2022 - 02/2015
6HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 04/2012
6HLA-G Antigens (HLA G)IBA
01/2022 - 06/2015
6Indicators and Reagents (Reagents)IBA
01/2021 - 01/2004
6Fumarate Hydratase (Fumarase)IBA
11/2020 - 01/2016
6Protein Isoforms (Isoforms)IBA
01/2020 - 04/2009
6Estrogens (Estrogen)FDA Link
01/2013 - 11/2008
5trans-sodium crocetinate (crocetin)IBA
10/2022 - 11/2021
5Pharmaceutical PreparationsIBA
01/2022 - 02/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 02/2013
5ErbB Receptors (EGF Receptor)IBA
03/2018 - 01/2006
5Sucrose (Saccharose)IBA
01/2018 - 08/2015
5Carrier Proteins (Binding Protein)IBA
08/2017 - 06/2011
5WD repeat containing planar cell polarity effectorIBA
10/2015 - 04/2004
5SERPIN-B5 (maspin)IBA
05/2012 - 04/2005
5Complementary DNA (cDNA)IBA
06/2009 - 04/2004
4VimentinIBA
02/2022 - 07/2012
4Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2022 - 08/2014
4Estrogen Receptor alphaIBA
01/2022 - 03/2009
4Programmed Cell Death 1 ReceptorIBA
01/2022 - 01/2016
4pembrolizumabIBA
11/2021 - 01/2019
4Long Noncoding RNAIBA
11/2020 - 01/2015
4atezolizumabIBA
10/2020 - 08/2017
4Death-Associated Protein KinasesIBA
11/2019 - 12/2012
4Fluorouracil (Carac)FDA LinkGeneric
10/2019 - 05/2006

Therapy/Procedure

94Therapeutics
10/2022 - 12/2003
38Drug Therapy (Chemotherapy)
04/2022 - 12/2003
31Cystectomy
01/2022 - 11/2002
18Neoadjuvant Therapy
04/2022 - 02/2011
15Immunotherapy
01/2022 - 04/2010
12Lasers (Laser)
03/2022 - 12/2002
12Adjuvant Chemotherapy
01/2021 - 08/2010
11Chemoradiotherapy
12/2021 - 02/2012
9Prostatectomy (Retropubic Prostatectomy)
07/2015 - 11/2008
7Radiotherapy
12/2021 - 12/2003
6Aftercare (After-Treatment)
01/2021 - 04/2004
5Transurethral Resection of Bladder
04/2022 - 07/2017